Protokinetix Patents – Insights & Stats (Updated 2023)

Protokinetix has a total of 32 patents globally, out of which 9 have been granted. Of these 32 patents, more than 81% patents are active. The USA is where Protokinetix has filed the maximum number of patents, followed by Canada and Europe (EPO). Parallelly, the USA seems to be the main focused R&D center of Protokinetix and is also the origin country of the firm.

Protokinetix was founded in the year 2002 by Clarence E. Smith and Michael Guzzetta. The company is a research and development firm that specializes in cell survival solutions.

Do read about some of the most popular patents of Protokinetix which have been covered by us in this article and also you can find Protokinetix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Protokinetix patent portfolio.

How many patents does Protokinetix have?

Protokinetix has a total of 32 patents globally. These patents belong to 7 unique patent families. Out of 32 patents, 26 patents are active.

How Many Patents did Protokinetix File Every Year?

Protokinetix Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantProtokinetix Applications FiledProtokinetix Patents Granted
202214
2021131
20201
2019
20181
20176
2016
201581
2014
20131
2012
2011

How many Protokinetix patents are Alive/Dead?

Worldwide Patents

Protokinetix Patent Portfolio

How Many Patents did Protokinetix File in Different Countries?

Protokinetix Worldwide Patent Filing

Countries in which Protokinetix Filed Patents

CountryPatents
United States Of America7
Canada5
Europe4
Korea (South)3
China3
Australia3
India1
New Zealand1
Hong Kong (S.A.R.)1

Where are Research Centres of Protokinetix Patents Located?

R&D Centres of Protokinetix

Most Cited Protokinetix Patent

US20150352155A1 is the most popular patent in the Protokinetix portfolio. It has received 4 citations so far.

List of Protokinetix Patents

Protokinetix PatentsTitle
US11096968B2Use Of Anti-Aging Glycoprotein For Enhancing Survival Of Neurosensory Precursor Cells
US8394362B2Gem Difluorinated C-Glycopeptides, Their Preparation And Their Use For The Preservation Of Biological Materials And/Or In Cryosugery
US20230142705A1Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of A Graft
US20210330712A1Use Of Anti-Aging Glycoprotein For Enhancing Survival Of Neurosensory Precursor Cells
US20210023142A1Use Of Anti-Aging Glycopeptides To Enhance Beta Cell Health, Survival And Improve Transplant Outcome
EP3407876B1Use Of Anti-Aging Glycoprotein For Enhancing Survival Of Neurosensory Precursor Cells
EP4093422A4Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of A Graft
EP4117705A1Use Of Anti-Aging Glycopeptides For Treatment Of Dry Eye Disease, Retinal Degenerative Diseases, Or Occular Inflammation
EP3152297A4Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome
CN106661549BApplication Of Anti-Aging Glycopeptide For Enhancing Pancreatic Cell Health, Survival And Improving Transplantation Effect
CN115568282AUse Of Anti-Aging Glycopeptide For Treating Dry Eye Disease, Retinal Degenerative Disease Or Ocular Inflammation
CN115427061AAnti-Aging Glycopeptides For Inhibiting Immune Rejection Of Graft
CA2588801CGem Difluorinated C-Glycopeptides, Their Preparation And Their Use For The Preservation Of Biological Materials And/Or In Cryosurgery
AU2015271608B9Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome
CA3171236A1Use Of Anti-Aging Glycopeptides For Treatment Of Dry Eye Disease, Retinal Degenerative Diseases, Or Occular Inflammation
CA3165196A1Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of A Graft
CA3011449A1Use Of Anti-Aging Glycoprotein For Enhancing Survival Of Neurosensory Precursor Cells
CA2950963A1Use Of Anti-Aging Glycopeptides To Enhance Beta Cell Health, Survival And Improve Transplant Outcome
AU2021233436A1Use Of Anti-Aging Glycopeptides For Treatment Of Dry Eye Disease, Retinal Degenerative Diseases, Or Occular Inflammation
AU2021211397A1Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of A Graft
KR2411834B1Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome
KR2023019070AUse Of Anti-Aging Glycopeptides For The Treatment Of Dry Eye Syndrome, Retinal Degenerative Diseases, Or Eye Inflammation
KR2022137037AUse Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of Grafts
IN384632BUse Of Anti Aging Glycopeptides To Enhance Pancreatic Cell Health Survival And Improve Transplant Outcome
HK1237814BUse Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome
NZ727749AUse Of Anti-Aging Glycopeptides To Enhance Beta Cell Health, Survival And Improve Transplant Outcome
US20170360844A1Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health Survival And Improve Transplant Outcome
US20150352155A1Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome
WO2021179081A1Use Of Anti-Aging Glycopeptides For Treatment Of Dry Eye Disease, Retinal Degenerative Diseases, Or Occular Inflammation
WO2021146812A1Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of A Graft
WO2017130148A1Use Of Anti-Aging Glycoprotein For Enhancing Survival Of Neurosensory Precursor Cells
WO2015184544A1Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome

What are Protokinetix’s key innovation segments?

What Technologies are Covered by Protokinetix?

The chart below distributes patents filed by Protokinetix in different countries on the basis of the technology protected in patents. It also represents the markets where Protokinetix thinks it’s important to protect particular technology inventions.

R&D Focus: How has Protokinetix’s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Protokinetix?

Related Articles

Capitainer Patents – Insights & Stats (Updated 2024)

Capitainer has a total of 50 patents globally, out of which 28 have been granted. Of these 50 patents, more than 84% patents are active. United States of America is where Capitainer has filed the maximum number of patents, followed by Europe (EPO) and India. Parallelly, Sweden seems to be

Read More »

Terasi Ab Patents – Insights & Stats (Updated 2024)

Terasi Ab has a total of 7 patents globally, out of which 2 have been granted. Of these 7 patents, more than 85% patents are active. Sweden is where Terasi Ab has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, Sweden seems

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.